Ogechi Blessing, 23, was shocked on Wednesday, April 1, when she discovered she could no longer afford one of the medicines helping her to stay alive: hydroxychloroquine.
Before the novel coronavirus pandemic, she could get a pack for N6,000 but when she called her regular dealer, he informed her that the new price was N25,000 – and it wasn’t an April Fool prank.
Agitated, she reached out to other sellers and visited at least eight pharmacies close to her house in Lagos. It was either the drug was out of stock or the price unaffordable.
She had to cry for help. Eventually, she found someone who volunteered to bear the expense. With the help of friends, she also discovered an online store that offered the medicine for a much lower price of N11,000.
Sometime in November 2019, Blessing, whose real name is not disclosed to prevent stigmatisation, was diagnosed with lupus – a chronic disease that causes the body’s immune system to attack its own tissues.
She has since been buying packs of hydroxychloroquine twice a month as she cannot afford to get them in bulk. One pack contains 20 tablets out of which she takes two tablets every day to manage the disease.
Buying the medicine was as easy as randomly walking into a drug store and placing an order.
“Since the COVID-19 spread to Nigeria, it has been a struggle finding this drug; a total struggle,” she said.
“It’s no longer something you walk into a shop and see, and it is very integral to the management of my health. I could literally die if I don’t have it.”
Because it is capable of causing cardiovascular diseases, lupus has been found to kill young people by triggering stroke or heart attacks.
Drugs used to treat the disease, which suppresses the immune system, also increase a person’s chances of contracting infections, including COVID-19.
Hydroxychloroquine is part of the drugs included in the World Health Organization (WHO) Model List of Essential Drugs.
The international body states that “essential medicines are intended to be available within the context of functioning health systems at all times in adequate amounts, in the appropriate dosage forms, with assured quality, and at a price the individual and the community can afford.”
Hydroxychloroquine particularly is used as part of frontline treatment for diseases, including malaria (in some countries), rheumatoid arthritis, lupus, and porphyria cutanea tarda.
The recent high demand for the drug can be attributed to the spread of a false claim that it “has been proven to be a solution to the coronavirus”, although WHO has maintained that there is no vaccine or antiviral medicine yet for the disease.
A young lady in Ibadan, Oyo State, who asked not to be named, shared her family’s experience with HumAngle.
Five years ago, her mother, a laboratory technologist, was diagnosed with rheumatoid arthritis, also an autoimmune disease which causes joint pains and other health complications.
A blister pack of hydroxychloroquine used to cost about N1,000 in the area. But when the family checked Kunle Ara Pharmacy on Wednesday, March 25, they were told the price had increased to N4,000.
The Point of Sale machine at the shop had no signal so her dad left briefly to get cash. By the time he returned about three hours later, he was told the price had risen to N5,000. Eventually, he paid N60,000 for 15 sachets, which should last for up to two and a half months.
“I think we are the ones victimising ourselves,” the lady said.
“Any opportunity we get, we want to extort people. I guess the price of that drug went up because they said it’s used to cure coronavirus.
“I believe we should always think about people who might not be able to buy this drug because the way water saves life is the way so many people depend on it for survival.”
Another resident of Ibadan, Akinyemi Muhammed, said that on March 22, soon after Oyo State recorded its index COVID-19 case, he saw an elderly man at Cran Pharmacy, Challenge, pay N12,000 for medicine that previously cost only N5,000.
“People were weeping in the shop because of inflated prices,” he recalls sadly.
Blessing said people should stop stocking hydroxychloroquine at home if they had no urgent need for it and urged the government to intervene to make the drug available.
“It’s literally nowhere; we searched all the big pharmacies: HealthPlus, MedPlus, all the pluses; they don’t have it. This is a major drug and people are not getting access to it for a life-threatening illness. It’s crazy.”
Jelili Kilani, Chairman of the Pharmaceutical Society of Nigeria (PSN), however, said it was not entirely the fault of pharmaceutical companies that the drug had become extraordinarily expensive.
“Pharmacists cannot sell drugs cheaper after buying at high prices,” he said. “I learnt there was a time a consignment of hydroxychloroquine came and the pack that should have gone for N20,000 was sold for N40,000 to the pharmacists.”
He said that no pharmacist would attempt to make 100 per cent profit from his products as a way of exploiting calamities faced by consumers because it was unprofessional.
READ THE FULL REPORT HERE: